Cargando…
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation
INTRODUCTION: Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. Approximately 5% of people with CF have residual function (RF) CFTR mutations that result in partially retained CFTR activity. Published literature on d...
Autores principales: | Sawicki, Gregory S., Konstan, Michael W., McKone, Edward F., Moss, Richard B., Lubarsky, Barry, Suthoff, Ellison, Millar, Stefanie J., Pasta, David J., Mayer-Hamblett, Nicole, Goss, Christopher H., Morgan, Wayne J., Duncan, Margaret E., Yang, Yoojung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727051/ https://www.ncbi.nlm.nih.gov/pubmed/36319933 http://dx.doi.org/10.1007/s41030-022-00202-y |
Ejemplares similares
-
Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials
por: VanDevanter, Donald R., et al.
Publicado: (2021) -
Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations
por: Hardisty, Gareth R., et al.
Publicado: (2021) -
Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial
por: Cunningham, Fiona, et al.
Publicado: (2022) -
Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
por: Crull, Mathew R., et al.
Publicado: (2016) -
A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis
por: Paynter, Alex, et al.
Publicado: (2022)